Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
1
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
2
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
3
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
4
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
5
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
6
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
7
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
Urinary tract
Kidney Tobacco smoking Arsenic and inorganic arsenic
X-radiation, gamma-radiation compounds
Trichloroethylene Cadmium and cadmium
compounds
Perfluorooctanoic acid
Printing processes
Welding fumes
Renal pelvis and Aristolochic acid, plants containing Aristolochic acid
ureter Phenacetin
Phenacetin, analgesic mixtures containing
Tobacco smoking
Urinary bladder Aluminum production 4-Chloro-ortho-toluidine
4-Aminobiphenyl Coal-tar pitch
Arsenic and inorganic arsenic compounds Dry cleaning
Auramine production Engine exhaust, diesel
Benzidine Hairdressers and barbers,
Chlornaphazine occupational exposure
Cyclophosphamide 2-mercaptobenzothiazole
Magenta production Pioglitazone
2-Naphthylamine Printing processes
Painting Soot
Rubber production industry Textile manufacturing
Schistosoma haematobium Tetrachloroethylene
Tobacco smoking
ortho-Toluidine
X-radiation, gamma-radiation
Eye, brain, and central nervous system
Eye Human immunodeficiency virus type 1 Solar radiation
Ultraviolet-emitting tanning devices
Ultraviolet emissions from welding
Brain and central X-radiation, gamma-radiation Radiofrequency
nervous system electromagnetic fields
(including from wireless
phones)
8
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
Endocrine glands
Thyroid Radioiodines, including Iodine-131
X-radiation, gamma-radiation
9
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
10
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
b
Leukaemia and/or Azathioprine Benzene
lymphoma Benzene
b
Bischloroethyl nitrosourea
Busulfan (BCNU)
1,3-Butadiene Chloramphenicol
Chlorambucil DDT
Cyclophosphamide Diazinon
Cyclosporine Dichloromethane (Methylene
chloride)
Epstein-Barr virus
Ethylene oxide
Etoposide with cisplatin and bleomycin
Etoposide
Fission products, including Strontium-90
Glyphosate
Formaldehyde
Hepatitis B virus
Helicobacter pylori
Magnetic fields, extremely low
Hepatitis C virus
frequency (childhood
Human immunodeficiency virus type 1 leukaemia)
Human T-cell lymphotropic virus type 1 Malathion
Kaposi sarcoma herpes virus Mitoxantrone
Lindane Nitrogen mustard
Melphalan Painting (childhood leukaemia
MOPP (vincristine-prednisone-nitrogen from maternal exposure)
mustard-procarbazine mixture) Petroleum refining,
Pentachlorophenol occupational exposures
Phosphorus-32 Polychlorinated biphenyls
Rubber production industry Polychlorophenols or their
Semustine (methyl-CCNU) sodium salts (combined
exposures)
Thiotepa
Radioiodines, including Iodine-
Thorium-232 and its decay products 131
Tobacco smoking Radon-222 and its decay
Treosulfan products
X-radiation, gamma-radiation Styrene
Teniposide
Trichloroethylene
2,3,7,8-Tetrachlorodibenzo-
para-dioxin
Tobacco smoking (childhood
leukaemia in smokers’
children)
Malaria (caused by infection
with Plasmodium
falciparum in holoendemic
areas)
11
List of Classifications by cancer sites with sufficient or limited evidence in
humans, Volumes 1 to 122 a
Cancer site Carcinogenic agents with sufficient Agents with limited evidence
evidence in humans in humans
12